Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology
- PMID: 30652645
- PMCID: PMC6629516
- DOI: 10.2174/1573397115666190116102451
Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology
Abstract
Interstitial Lung Disease (ILD) is a well-known complication of rheumatoid arthritis (RA) which often results in significant morbidity and mortality. It is often diagnosed late in the disease process via descriptive criteria. Multiple subtypes of RA-ILD exist as defined by chest CT and histopathology. In the absence of formal natural history studies and definitive diagnostics, a conventional dogma has emerged that there are two major subtypes of RA-ILD (nonspecific interstitial pneumonia (NSIP) and Usual Interstitial Pneumonia (UIP)). These subtypes are based on clinical experience and correlation studies. However, recent animal model data are incongruous with established paradigms of RA-ILD and beg reassessment of the clinical evidence in order to better understand etiology, pathogenesis, prognosis, and response to therapy. To this end, here we: 1) review the literature on epidemiology, radiology, histopathology and clinical outcomes of the various RAILD subtypes, existing animal models, and current theories on RA-ILD pathogenesis; 2) highlight the major gaps in our knowledge; and 3) propose future research to test an emerging theory of RAILD that posits initial rheumatic lung inflammation in the form of NSIP-like pathology transforms mesenchymal cells to derive chimeric disease, and subsequently develops into frank UIP-like fibrosis in some RA patients. Elucidation of the pathogenesis of RA-ILD is critical for the development of effective interventions for RA-ILD.
Keywords: Computed Tomography (CT); Histology; Nonspecific Interstitial Pneumonia (NSIP); Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD); Usual Interstitial Pneumonia (UIP); animal models; fibrosis; inflammation..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Conflict of interest statement
CONFLICT OF INTEREST
The authors declare no conflict of interest, financial or otherwise. E.W. is supported by a training grants from the NIH (MSTP T32 GM007356 and T32 AR053459). R.M.K. is supported by private and internal grants (The Parker B. Francis Fellowship Award, Univ of Rochester DOM Faculty Pilot Project Award). H.R. is supported by an NIH grant (K08 AR067885). C.T.R. is supported by grants from the NIH (R01 AR056702 and R01 AR069000). E.M.S. is supported by grants from the NIH (P30 AR069655 and R01 AR056702).
Figures
Similar articles
-
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.Clin Rheumatol. 2017 Jul;36(7):1493-1500. doi: 10.1007/s10067-017-3707-5. Epub 2017 Jun 6. Clin Rheumatol. 2017. PMID: 28585060
-
High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival.Respir Med. 2017 May;126:100-104. doi: 10.1016/j.rmed.2017.03.027. Epub 2017 Mar 30. Respir Med. 2017. PMID: 28427540
-
Increased circulating Wnt5a protein in patients with rheumatoid arthritis-associated interstitial pneumonia (RA-ILD).Immunobiology. 2019 Jul;224(4):551-559. doi: 10.1016/j.imbio.2019.04.006. Epub 2019 Apr 30. Immunobiology. 2019. PMID: 31072629
-
Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.Chest. 2009 Nov;136(5):1397-1405. doi: 10.1378/chest.09-0444. Chest. 2009. PMID: 19892679 Free PMC article. Review.
-
Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients.Drugs Aging. 2020 Jan;37(1):11-18. doi: 10.1007/s40266-019-00727-z. Drugs Aging. 2020. PMID: 31773418 Review.
Cited by
-
Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease.Int J Mol Sci. 2023 Sep 25;24(19):14509. doi: 10.3390/ijms241914509. Int J Mol Sci. 2023. PMID: 37833957 Free PMC article. Review.
-
Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathway.Adv Rheumatol. 2023 Aug 28;63(1):45. doi: 10.1186/s42358-023-00325-z. Adv Rheumatol. 2023. PMID: 37641106
-
The Role of Autophagy and Apoptosis in Affected Skin and Lungs in Patients with Systemic Sclerosis.Int J Mol Sci. 2023 Jul 7;24(13):11212. doi: 10.3390/ijms241311212. Int J Mol Sci. 2023. PMID: 37446389 Free PMC article. Review.
-
Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg mice.Arthritis Res Ther. 2023 Feb 2;25(1):17. doi: 10.1186/s13075-022-02985-6. Arthritis Res Ther. 2023. PMID: 36732826 Free PMC article.
-
Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy-Lysosome Pathway.Molecules. 2022 Dec 2;27(23):8475. doi: 10.3390/molecules27238475. Molecules. 2022. PMID: 36500562 Free PMC article.
References
-
- O’Dwyer DN, et al., Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD). Eur J Intern Med, 2013. 24(7): p. 597–603. - PubMed
-
- Aubart F, et al., High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis. J Rheumatol, 2011. 38(6): p. 979–82. - PubMed
-
- Luukkainen R, et al., Relationship of rheumatoid factor to lung diffusion capacity in smoking and non-smoking patients with rheumatoid arthritis. Scand J Rheumatol, 1995. 24(2): p. 119–20. - PubMed
-
- Gibofsky A, Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care, 2012. 18(13 Suppl): p. S295–302. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
